Skip to main content
OpenTrials

Clinical trial condition

Solid Malignancies

Explore clinical trials studying Solid Malignancies. Study availability and eligibility vary by location and protocol.

17 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Solid Malignancies trial results

Recruiting

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

NCT06823167

Conditions
Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +4 more
Locations
  • City Of Hope Duarte, California, United States
  • University of California Los Angeles, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Yale University Medical Center New Haven, Connecticut, United States
View all 24 locations
View Trial Details
Active, not recruiting

Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens

NCT02537418

Conditions
Solid Malignancies
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
  • Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
  • Cancer Centre of Southeastern Ontario at Kingston Kingston, Ontario, Canada
View Trial Details
Completed

FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB Expression

NCT02325739

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations
  • University of California LA Santa Monica Location Los Angeles, California, United States
  • Massachusetts General Hospital Oncology Dept Boston, Massachusetts, United States
  • Uni Of TX MD Anderson Cancer Cntr Houston, Texas, United States
  • Novartis Investigative Site Shanghai, Shanghai Municipality, China
View all 27 locations
View Trial Details

Related conditions